New York University

Human eye, for article on whole-eye transplant

New York surgeons perform world’s first successful eyeball transplant

By / / Good News For Humankind

Whole-eye transplant surgery has been performed successfully for the first time, with a team at NYU Langone Health spending more than 20 hours combining a donor eyeball, a partial face transplant, and a stem cell infusion into the optic nerve. The patient, Aaron James, lost much of his face in a 2021 electrical accident, and surgeons had carefully preserved his optic nerve in anticipation of exactly this kind of operation. Doctors say the transplanted eye is healthy and blood is flowing to the retina, though James has not regained sight. Restoring vision may still be years away, but this opens a real door for people with catastrophic eye injuries — proof that something once considered impossible is now a starting point.

Surgeons operating, for article on pig kidney xenotransplant

Pig kidney functions in human patients for two full months for first time ever

By / / Good News For Humankind

A genetically modified pig kidney kept working inside a human body for 61 days at NYU Langone Health — the longest a non-human organ has ever functioned in a person. Surgeons used a simplified approach, transplanting a kidney from a pig with just one gene edit and leaving the thymus gland attached to help the recipient’s immune system accept it. Around 100,000 Americans are on the kidney waitlist at any given time, and researchers hope pig organs could one day help close that gap. The team is now preparing for clinical trials pending FDA approval. For the thousands waiting on a kidney that may not arrive in time, this is real, tangible hope.

Empty bottles of alcohol, for article on psilocybin-assisted therapy

First-of-its-kind study reveals how psilocybin helps treat alcohol dependence

By / / Good News For Humankind

Psilocybin-assisted therapy helped 13 people who had struggled with heavy drinking reach the root of what they were drinking to escape, according to new interviews published in Psychology of Addictive Behaviors. Participants described years of self-blame and isolation quieting after their sessions, replaced by something many had never felt toward themselves: compassion. They credited the trained therapists and carefully held setting as much as the medicine itself, calling both essential to feeling safe enough to face old pain. The researchers are honest about the study’s limits, including a mostly white, higher-income participant group. Still, as Oregon and Colorado open legal pathways, these first-person accounts offer a hopeful glimpse of how psychedelic care might one day reach the communities who need healing most.